Symbicort SMART Satisfaction From Patient Perspective 2009
Completed
- Conditions
- Asthma
- Registration Number
- NCT00946452
- Lead Sponsor
- AstraZeneca
- Brief Summary
To characterize the level of asthma control and patient satisfaction amongst diagnosed asthma sufferers who are currently receiving Symbicort Maintenance and Reliever Therapy (SMART) in Malaysia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 205
Inclusion Criteria
- Have been prescribed Symbicort SMART (1 or 2 inhalation twice daily) by their Dr's for the past 3 months
- Informed consent
Exclusion Criteria
- Symbicort SMART treatment < 3 months
- Patients requiring short courses of oral steroids more than twice in a month
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Score level of Asthma Control Test (ACT) After 3 months on SMART - once Score level of Satisfaction in Asthma Treatment Questionnaire (SATQ) After 3 months on SMART - once
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Research Site
🇲🇾Petaling Jaya, Selangor, Malaysia